UNH UNITEDHEALTH GROUP INC
What matters nowUpdated 4 h ago
- UnitedHealth reported Q3 2026 results on Oct 13: adjusted EPS of $4.69 against $2.92 a year earlier, on revenue of $112.7 billion versus $113.2 billion 1. The medical care ratio improved to 88.4% from 89.9%, helped by $610 million of favorable prior-period reserve development, and the 2026 adjusted EPS outlook was raised to at least $20.50, above the $19.50 to $20.00 range set in July 1.
- The pooled 24/7 venue price was $383.66 at 16:06 UTC on Oct 13, up 0.41% from the previous close of $382.10. Detected moves of -1.97% on Oct 8 and +2.84% on Oct 9 coincide with the CMS 2027 Medicare Advantage star-ratings release 2, while the largest recent detected moves were -5.82% on May 15 and +5.24% on June 4.
- On trailing twelve-month figures to June 30, 2026, revenue was $450.1 billion, up 6.5% year over year, while EPS of $15.55 was down 32.6% and the operating margin was 4.8%. With a $347.2 billion market cap, the stock trades at 24.7 times earnings, 15.1 times EV/EBITDA and a 6.8% free-cash-flow yield. Insiders sold 2,469 shares worth $944,910 in three sales over the last 180 days and bought none.
- Segment figures from Q3 2026: Medicare Advantage membership reached 7.6 million at Sep 30 with a 3.3% segment operating margin; Optum Health revenue fell 10% year over year with a 3.2% operating margin; Optum Insight earned a 23.4% operating margin; and Optum Rx adjusted scripts fell to 393 million from 414 million while its operating earnings rose.
- Next: CMS published the 2027 star ratings on Oct 8, with about 71% of Medicare Advantage enrollees in contracts rated four stars or higher, and star ratings drive quality bonus payments that feed UnitedHealthcare's 2028 Medicare outlook 2. UnitedHealthcare's 2027 Medicare lineup offers a $0-premium option to about 90% of people with access to a Medicare Advantage plan 3. The Q4 and full-year 2026 results are estimated for Jan 27, 2027 and are not yet confirmed.
SEC Form 8-K (UnitedHealth Q3 2026 earnings release) · Oct 13
CMS fact sheet, 2027 Medicare Advantage and Part D Star Ratings · Oct 8
UnitedHealth Group newsroom · Oct 1
Valuation & fundamentalsFull financials →
TTM through 2026-06-30 from SEC filings (some quarters derived from annual and year-to-date figures). Ratios use our pooled 24/7 price. Quarterly statements →
Every venue
| Venue | Price | vs pool | 24h vol | Open int. | Funding 8h |
|---|---|---|---|---|---|
| bybit perp UNHUSDT · just now | 378.72 | −0.12% | $1.6M | $249.1K | 0.0000% |
| binance perp UNHUSDT · just now | 379.28 | +0.02% | $1.6M | $199.9K | 0.0289% |
| bitget perp UNHUSDT · just now | 378.42 | −0.20% | $1.0M | $838.1K | 0.0217% |
| okx perp UNH-USDT-SWAP · just now | 379.34 | +0.04% | $608.0K | $148.5K | 0.0178% |
Pooled price = volume-weighted median of venues within 2% of each other. Venue markets for stocks, indices and gold are 24/7 perpetual contracts; they track but are not the official exchange price.
Open interest, 120 days
US$ millions, all venues
Funding, 120 days
Annualised %, OI-weighted. Positive: longs pay shorts.
NewsAll news →
UnitedHealth Q3 2026 adjusted EPS $4.69 vs $2.92 a year ago; 2026 adjusted EPS floor raised to $20.50
UnitedHealth reported third-quarter 2026 revenue of $112.7 billion, slightly below $113.2 billion a year earlier, and adjusted EPS of $4.69 against $2.92.
CMS releases 2027 Medicare Advantage Star Ratings; 71% of enrollees in 4-star-plus contracts
CMS published the 2027 Medicare Advantage and Part D Star Ratings on October 8, 2026.
UnitedHealthcare unveils 2027 Medicare plan lineup focused on $0 premiums and lower costs
UnitedHealthcare said its 2027 Medicare plans will focus on affordability and simpler benefits.
UnitedHealth names Jodee Kozlak its first chief administrative officer, effective Sept. 28
UnitedHealth Group created a chief administrative officer role and named Jodee Kozlak to it, effective September 28, 2026.
UnitedHealth sets the date for its Q3 2026 earnings release
UnitedHealth announced on September 15, 2026 the date of its third-quarter 2026 earnings release.
Analyst says UnitedHealthcare looks most exposed in draft 2027 star-ratings cutpoints
CMS released draft 2027 star-rating cutpoints to plans in early September 2026.
Optum sells minority stake in Florida WellMed clinics to TPG
UnitedHealth's Optum sold a minority interest in part of its Florida WellMed clinic operations to the private equity firm TPG, according to a Bloomberg interview with CFO Wayne DeVeydt published September 9, 2026.
UnitedHealth leaders to take investor questions at Wells Fargo healthcare conference
UnitedHealth disclosed in a September 8, 2026 filing that senior leaders would take questions in an interview format at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, starting at 8:00 a.m.
Luigi Mangione pleads guilty to federal stalking charges in killing of UnitedHealthcare CEO
Luigi Mangione pleaded guilty on August 14, 2026, in Manhattan federal court to federal stalking charges in the killing of UnitedHealthcare CEO Brian Thompson, reversing his earlier not-guilty plea.
UnitedHealth Q2 2026 adjusted EPS $6.38 vs $4.08; full-year adjusted EPS guidance raised to $19.50-$20.00
UnitedHealth reported second-quarter 2026 revenue of $112.0 billion and adjusted EPS of $6.38, up from $4.08 a year earlier.
UnitedHealth publishes independent review findings: 23 recommendations, all implemented
UnitedHealth released an update to its Independent Review Program covering risk assessment, care services management, prescription drug manufacturer discount practices and HouseCalls diagnosis coding.
Optum Financial closes acquisition of Alegeus Technologies
Optum Financial closed its acquisition of Alegeus Technologies on July 2, 2026.
FTC pulls its OptumRx insulin pricing case to review a final settlement
The Federal Trade Commission withdrew its in-house case against OptumRx from adjudication so it could review a final settlement, Law360 reported on June 15, 2026.
UnitedHealth board raises quarterly dividend to $2.32 per share
UnitedHealth's board authorized a quarterly cash dividend of $2.32 per share, up from $2.21 in March.
Optum Rx launches fee-based pharmacy care model that drops list-price and volume pricing
Optum Rx introduced a fee-based pharmacy care model on May 11, 2026, offered to every Optum Rx PBM client.